Follow us :

Gallbladder Cancer: Symptoms, Causes, Types, and PET-CT as a Diagnostic Tool

Talk to Health Expert

Dr. Nikunj Jain

Dr. Nikunj Jain

Co-Founder and HOD - Nuclear Medicine ,

MBBS, DRM, DNB, FEBNM, FANMB, Dip. CBNC

Gallbladder Cancer: Symptoms, Causes, Types, and PET-CT as a Diagnostic Tool

Gallbladder Cancer occurs when healthy cells lining the gallbladder start developing in an uncontrolled way and change into cancer cells. Adenocarcinoma is the type of cancer that can arise from cells of an adenoma in the lining of an adenoma from the inside of the gal bladder (gallbladder). Of these two types, most (by far) gallbladder cancers are of the first type.

 

The disease may be discovered by chance if someone has an imaging test or surgery because they were being treated for an unrelated condition, such as gallstones. The stage of gallbladder cancer is the degree or spread of the cancer. The results of an examination, imaging tests, and, if needed, tests that measure the amount of disease are used by doctors to understand how much disease is present and to determine treatment.

Symptoms of Gallbladder Cancer

Gallbladder cancer doesn't exhibit any symptoms during the very first stages. Symptoms may be similar to those of gallstones and other gallbladder diseases. Possible symptoms include:

Abdominal pain: Persistent pain or discomfort in the upper-right part of the abdomen may occur, particularly as the disease progresses.

Jaundice: Yellowing of the skin and eyes can develop if the tumour blocks the bile ducts and prevents bile from draining normally.

Nausea and vomiting: Some patients may experience nausea, vomiting, or discomfort after eating.

Loss of appetite and unexplained weight loss: Reduced appetite and unintentional weight loss may occur with advancing disease.

Abdominal swelling: Some patients may develop abdominal swelling or a feeling of fullness.

Fever and general weakness: Fever, tiredness, or weakness may occur, although these symptoms are not specific to gallbladder cancer.

Causes and Risk Factors of Gallbladder Cancer

Gallbladder cancer's actual cause is unknown in most cases. It arises from abnormalities of the cells' growth and division in the genetic material. There are certain conditions and factors that make one more likely to develop the disease.

Gallstones: Gallstones are associated with an increased risk of gallbladder cancer, particularly when they cause long-term irritation or inflammation. However, most people with gallstones do not develop cancer.

Chronic gallbladder inflammation: Long-standing inflammation of the gallbladder may increase the risk of abnormal cellular changes.

Gallbladder polyps: Some gallbladder polyps have a higher risk of malignancy, depending on their size and other characteristics. Most polyps are not cancerous.

Age and sex: Gallbladder cancer is more common in older adults and occurs more frequently in women than in men.

Certain bile duct conditions: Some structural abnormalities involving the bile ducts may increase the risk of gallbladder cancer.

Family history and genetic factors: A family history of gallbladder cancer or certain inherited conditions may contribute to risk in some individuals.

People with one or more risk factors are not guaranteed to develop gallbladder cancer. Likewise, the disease is also found in persons without known risk factors.

Types of Gallbladder Cancer

Gallbladders that have cancer may be classified based on the type of cells in which the cancer originates. The type of the disease is identified to help doctors understand the disease and develop a course of treatment.

1. Adenocarcinoma

Adenocarcinoma is the most common type of gallbladder cancer. It is formed from a type of glandular cells that line the inside of the gallbladder. The growth/restructuring of the various forms may differ in rates of increase.

2. Papillary Adenocarcinoma

A less common type of papillary adenocarcinoma grows in finger-like projections. The spots can be less prone to invade surrounding tissues at an early stage than other kinds of tumours, but there are variations.

3. Squamous Cell Carcinoma

Squamous cell carcinoma is a rare type that develops from squamous cells and tends to be aggressive in the gallbladder. It may spread fast and can have a poorer prognosis.

4. Adenosquamous Carcinoma

Adenosquamous carcinoma is a mixture of two cell types, glandular and squamous, both of which can form a cancer. Occasionally unusual and may be more aggressive than a typical adenocarcinoma. Traditionally, the exact type of tumour will be identified based on the tissue that is retrieved with a biopsy or surgery (when applicable).

How Is Gallbladder Cancer Diagnosed?

To diagnose gallbladder cancer, doctors review the patient's history, perform a physical examination, and order lab tests and imaging scans. None of the tests is appropriate for all patients.

Ultrasound: An abdominal ultrasound is often one of the first investigations used to examine the gallbladder. It can help identify gallstones, thickening of the gallbladder wall, masses, and changes in nearby structures.

CT scan: A computed tomography (CT scan) with the use of a contrast dye can help give detailed images of the gallbladder and the liver, and any other lymph nodes in the abdomen.

Blood tests: These can be used to check liver function and help determine if there is any blockage in the bile duct. In some individuals, the presence of tumour markers like CA 19-9 and CEA may be checked, but it isn't possible to diagnose gallbladder cancer using these markers alone.

Biopsy: When a sample is removed and studied with a microscope. Decision for biopsy prior to treatment is dependent on the clinical circumstance and the treatment that is planned.

Role of PET-CT in Gallbladder Cancer Diagnosis

PET-CT is a combination of positron emission tomography (PET) and computed tomography (CT). PET can give information about metabolic activity in the tissues, whereas CT can give information about the structure of the tissues. The combined images can help assess how far the disease has spread among certain patient populations with suspected cancer.

 

A radioactive substance, called fluorodeoxyglucose (FDG), is the tracer commonly used in this scan. Some cancer cells consume glucose more quickly than the rest of the body, causing the area of the tumour to show up as a “hot spot” on the images. However, hypermetabolism does not necessarily indicate malignancy, and may indicate infection or inflammatory processes.

1. Assessing Possible Cancer Spread

Doctors might use PET-CT to get more information about where the gallbladder cancer may have spread if they need more information about lymph nodes or other organs. It is used as a means to interpret its findings in conjunction with other investigations such as CT, MRI, and clinical information.

2. Supporting Treatment Planning

In some instances, PET-CT may be able to offer more information that aids in determining the amount of disease and which treatment options are best for the patient. It may be especially helpful if standard imaging is inconclusive about the need for distant imaging diagnosis.

3. Evaluating Suspected Recurrence

If there is a concern that the gallbladder cancer has come back or spread, it may be necessary to have a PET-CT after treatment. This will depend on the symptoms of the patient as well as any previous treatment history and any other investigations which may have been obtained. Note that PET-CT is not routinely used in the initial diagnosis of suspected gallbladder tumour. Initially, ultrasound, contrast CT (and MRI) are important.

 

Some cancer types may not be detected by PET-CT, and gallbladder cancer cannot be definitively diagnosed using PET-CT alone. In some cases, it may be necessary to take out and examine the tissue. Molecular Diagnostics and Therapy offers diagnostic imaging services. Patients are advised to consult with their physician beforehand on whether the PET-CT scan is applicable for them or not and whether they wish to have the scan prior to making a reservation.

Treatment Options for Gallbladder Cancer

Treatment will vary for different types of cancer, depending on the stage, location, and health status of the patient. Sometimes it also includes surgery, chemotherapy, or radiotherapy (in some cases), targeted treatment, as well as Immunotherapy. Sometimes, surgery can be performed, in addition to offering hope for a cure, if the cancer is found early enough in disease progression so that all traces of it may be completely removed. If the disease becomes more severe, it might require systemic medications that can control the spread of disease and/or reduce symptoms or improve quality of life. Treatment is based on individual clinical findings and imaging and pathological findings. Early medical assessment will be carried out and a diagnosis made, and the doctor will be guided on further tests.

Conclusion

Gallbladder cancer may be a serious condition and might not be recognized in the early stages. Symptoms include: abdominal pain, jaundice, nausea, loss of appetite, and weight loss, but could be from other non-cancer sources. You can be diagnosed with gallbladder cancer by an ultrasound, computed tomography (CT) scan, magnetic resonance imaging (MRI) scan, and a biopsy of the tissue.

 

Sometimes the PET-CT scan can be useful in deciding on treatment and/or assessing the spread of disease, or suspected recurrence of the cancer. Discuss which tests are needed with your doctor. Molecular Diagnostics and Therapy offers the most advanced services and technologies to the patient, always in the best way and with comfort.

Frequently Asked Questions

Early gallbladder cancer may not cause noticeable symptoms. When symptoms develop, they may include upper-right abdominal pain, nausea, loss of appetite, or unexplained weight loss.

The exact cause is often unknown. Risk factors include gallstones, chronic gallbladder inflammation, certain bile duct abnormalities, older age, and some genetic factors.

Adenocarcinoma is the most common type. Other, less common types include papillary adenocarcinoma, squamous cell carcinoma, and adenosquamous carcinoma.

Doctors may use ultrasound, contrast-enhanced CT, MRI or MRCP, blood tests, and tissue examination when appropriate. The tests selected depend on the patient's condition and clinical findings.

PET-CT may help evaluate suspected cancer and assess possible spread in selected cases. However, it is not usually the first test for a suspected gallbladder tumour and cannot confirm cancer on its own.

Gallstones are associated with an increased risk of gallbladder cancer, but most people with gallstones never develop the disease.

Yes. Gallbladder cancer may spread to nearby structures, lymph nodes, the liver, or distant organs. The extent of spread is assessed using clinical evaluation and appropriate imaging tests.

Persistent upper-right abdominal pain, unexplained weight loss, or ongoing digestive symptoms should be evaluated by a healthcare professional. Yellowing of the skin or eyes requires prompt medical assessment because it can indicate bile duct obstruction or another serious condition.

In News

Download Our App

Get Our Mobile App
for Easy Access

Book tests, view reports, and manage your health records on the go. Experience convenient healthcare with Molecular Diagnostics and Therapy.

  • ✔ Book tests & home collection
  • ✔ View reports instantly
  • ✔ Track health history
  • ✔ Get notifications & reminders
  • ✔ Easy appointment management
Your Health Companion
Scan to download Molecular Diagnostics and Therapy App

Scan to download the app